NASDAQFinancialsBanks - RegionalSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for TRST yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Net interest income grows at least 10% YoY | TrustCo Bank grows net interest income by about 10% yearly. | Under Pressure | net interest income growth falls below 7% YoY | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 4 of 4 supplied quarters. Management reported: “We believe that this ongoing repricing reflects disciplined loan production aligned with current market conditions.” “The consistent growth in the loan portfolio will likely enhance net interest income in the quarters ahead.” |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a regional financial business with a measured, execution-led thesis, not a turnaround case. The thesis is intact, and the latest signal improved from mixed to mildly favorable, though earnings quality remains fragile.
Valuation is stretched, at a 1.23 premium versus peers, while the expectations gap is modestly positive at 0.15. The evidence suggests some optimism is already reflected, but it does not show the full combination of expensive valuation, weak execution, and turbulent conditions.
Near term, management’s focus on loan growth, repricing, and deposit pricing is showing results: net interest income and net interest margin both increased from 2025-Q3 to 2026-Q3. Share repurchases and a higher quarterly dividend also show capital-allocation follow-through, but a guidance cut remains a meaningful risk; the estimated miss risk is low, with the smaller size and a past deep miss worth noting.
Over the next few quarters, the thesis depends on continued progress in net interest income and margin, alongside steady execution on capital returns. A guidance cut or rate cuts from the current 3.88% would weigh on the setup, while continued earnings strength and higher guidance from sector bellwethers could support sector momentum.
For the next 1 to 3 years, TRST’s business case is intact but not free of tension: operating progress is real, while earnings quality is fragile and valuation is stretched. The multi-year view hinges on sustained execution without a guidance setback. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Quarterly dividend remains at $0.38 per share | It keeps paying a steady dividend of $0.38 per share. | Intact | dividend per share falls below $0.38 | Dividend per share: $0.38 per share FY2026-Q2; GAAP. Published target: >= $0.38 per share per quarter. Target period is not explicitly aligned with this observation. Aug 10, 20260.38 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Complete repurchase of two million shares in 2026 | The bank is buying back shares, aiming for two million in 2026. | Intact | repurchases fall below 1.5 million shares by end of 2026 | Required source inputs unavailable Cannot calculate Share repurchases from the available matching source inputs. Missing inputs are not treated as zero. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 4 of 4 supplied quarters. Management reported: “Page | 2 2 During the third quarter of 2026, the Bank remained focused on capital deployment and allocation, guided by a disciplined framework, with a dividend increase, and share repurchases, these serve as key tools to enhance shareholder value.” “The ongoing repurchase of shares and regular payment of our recently-increased quarterly dividend work together to enhance shareholder value.” Delivery assessment Nov 4, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.